Sonova H Ag

Research Sonova H Ag (SOON) on Bullrun: market cap CHF 13.92B, P/E 26.0, dividend yield 2.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CHF 13.92B; P/E is 26.0; dividend yield is 2.0%.

Peer valuation comparison

Latest P/E is 26.04x versus a Healthcare sector median of 24.46x (6.5% above).

Latest dividend yield is 2.01% versus a Healthcare sector median of 2.11% (4.7% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2026CHF 3.61BCHF 430.60MCHF 631.80M73.7%7.22CHF 722.00MCHF 1.71BCHF 2.61B
FY2025CHF 3.87BCHF 540.50MCHF 656.10M72.0%9.04CHF 686.90MCHF 1.76BCHF 2.66B
FY2024CHF 3.63BCHF 601.00MCHF 624.70M72.0%10.05CHF 513.60MCHF 1.79BCHF 2.47B
FY2023CHF 3.74BCHF 647.50MCHF 629.60M70.5%10.72CHF 413.90MCHF 1.81BCHF 2.21B
FY2022CHF 3.36BCHF 649.00MCHF 834.50M73.2%10.35CHF 610.50MCHF 1.48BCHF 2.41B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-29CHF 13.92B26.02.0%4.7

Dividend history

Latest trailing dividend snapshot: annual dividend/share 4.7 CHF, yield 2.0%.

YearDividends/share
FY20264.7 CHF
FY20254.4 CHF
FY20244.3 CHF
FY20234.6 CHF
FY20224.4 CHF

About Sonova H Ag

Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Hearing Instruments, Cochlear Implants, and Lifestyle-Aligned segments.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Sonova H Ag's market cap?

Sonova H Ag's market capitalization is CHF 13.92B.

What is Sonova H Ag's P/E ratio?

Sonova H Ag's price-to-earnings (P/E) ratio is 26.0.

Does Sonova H Ag pay a dividend?

Sonova H Ag has a dividend yield of 2.0%.

What does Sonova H Ag do?

Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Hearing Instruments, Cochlear Implants, and Lifestyle-Aligned segments.